“Comparison of intravitreal ranibizumab and aflibercept in patients with choroidal neovascularization in pathologic myopia”, Ukr. j. ophthalmol. , no. 5, pp. 34–38, Jun. 2026, doi: 10.31288/oftalmolzh201753438.